ISSN 1472-4683. Published by i-Base.
Contents. 
Previous page. 
Next page.
On June 23, 2008, FDA approved a new Aptivus (tipranavir) oral solution (100 mg/mL). The product label has been updated to include dosing recommendations for pediatric patients 2-18 years of age.
In addition, information regarding oral and parenterally administered midazolam was updated in the Contraindication and Drug Interactions section.
Source:
FDA list serve (23 June 2008).
http://www.fda.gov/oashi/aids/listserve/listserve2008.html#062308
Top | htb | Home | Order & subscribe | Contact | Site map | Access